TGF-β3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion

Developmental Dynamics

Volumn 227, Issue 3, 2003, Pages 387-394

  Cui, Xiao Mei ^a   Chai, Yang ^a   Chen, Jucheng ^a   Yamamoto, Tadashi ^a   Ito, Yoshihiro ^a   Bringas, Pablo ^a   Shuler, Charles F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epithelial mesenchymal transformation; Medial edge epithelium; Palatogenesis; Proliferation; SMAD2; SMAD3; TGF 3

Indexed keywords

BROXURIDINE; DNA; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA3; DNA BINDING PROTEIN; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN; SMAD3 PROTEIN, MOUSE; TGFB3 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENT; DIFFERENTIATION; DNA SYNTHESIS; EMBRYO; EPITHELIUM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PALATE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL DIVISION; GENE EXPRESSION REGULATION; HARD PALATE; METABOLISM; PRENATAL DEVELOPMENT; TIME; WESTERN BLOTTING;

MURINAE;

ANIMALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; MICE; PALATE; PALATE, HARD; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; SMAD3 PROTEIN; TIME FACTORS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0037664291     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.10326     Document Type: Article

References (31)

1. Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. 1997. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272:27678-27685.
2. Brunet CL, Sharpe PM, Ferguson MW. 1995. Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion. Int J Dev Biol 39:345-355.
3. Carette MJ, Ferguson MW. 1992. The fate of medial edge epithelial cells during palatal fusion in vitro: an analysis by Dil labelling and confocal microscopy. Development 114:379-388.
4. Cui XM, Shuler CF. 2000. The TGF-β type III receptor is localized to the medial edge epithelium during palatal fusion. Int J Dev Biol 44:397-402.
5. Cui XM, Warburton D, Zhao J, Crowe DL, Shuler CF. 1998. Immunohistochemical localization of TGF-β type II receptor and TGF-β3 during palatogenesis in vivo and in vitro. Int J Dev Biol 42:817-820.
6. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF. 1999. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 19:2495-2504.
7. Esparza-López J, Montiel JL, Vilchis-Landeros MM, Okadome T, Miyazono K, López-Casillas F. 2001. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J Biol Chem 276:14588-14596.
8. Gehris AL, Greene RM. 1992. Regulation of murine embryonic epithelial cell differentiation by transforming growth factors beta. Differentiation 49:167-173.
9. Griffith CM, Hay ED. 1992. Epithelial-mesenchymal transformation during palatal fusion: carboxyfluorescein traces cells at light and electron microscopic levels. Development 116:1087-1099.
10. Hartsough MT, Mulder KM. 1997. Transforming growth factor-β signaling in epithelial cells (review). Pharmacol Ther 75:21-41.
11. Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-beta signaling from cell membrane to nucleus through SMAD proteins (review). Nature 390:465-471.
12. Ito Y, Sarkar P, Mi Q, Wu N, Bringas P Jr, Liu Y, Reddy S, Maxson R, Deng C, Chai Y. 2001. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis. Dev Biol 236:181-194.
13. Kaartinen V, Voncken JW, Shuler CF, Warburton D, Bu D, Heisterkamp N, Groffen J. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421.
14. Kaartinen V, Cui XM, Heisterkamp N, Groffen J, Shuler CF. 1997. Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dyn 209:255-260.
15. Martinez-Alvarez C, Tudela C, Pérez-Miguelsanz J, O'Kane S, Puerta J, Ferguson MWJ. 2000. Medial edge epithelial cell fate during palatal fusion. Dev Biol 220:343-357.
16. Massagué J. 1990. The transforming growth factor-beta family (review). Annu Rev Cell Biol 6:597-641.
17. Massagué J. 1998. TGF-beta signal transduction (review). Annu Rev Biochem 67:753-791.
18. Mori C, Nakamura N, Okamoto Y, Osawa M, Shiota K. 1994. Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labeling of DNA fragmentation. Anat Embryol (Berl) 190:21-28.
19. Nakao A, Fujii M, Matsumura R, Kumano K, Salto Y, Miyazono K, Iwamoto I. 1999. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104:5-11.
20. Nomura M, Li E. 1998. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393:786-790.
21. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T. 1995. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11:409-414.
22. Shuler CF. 1995. Programmed cell death and cell transformation in craniofacial development (review). Crit Rev Oral Biol Med 6:202-217.
23. Shuler CF, Guo Y, Majumder A, Luo RY. 1991. Molecular and morphologic changes during the epithelial-mesenchymal transformation of palatal shelf medial edge epithelium in vitro. Int J Dev Biol 35:463-472.
24. Shuler CF, Halpern DE, Guo Y, Sank AC. 1992. Medial edge epithelium fate traced by cell lineage analysis during epithelial-mesenchymal transformation in vivo. Dev Biol 154:318-330.
25. Souchelnytskyi S, Tamaki K, Engstrom U, Wernstedt C, ten Dijke P, Heldin CH. 1997. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J Biol Chem 272: 28107-28115.
26. Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM, Dooley S. 2000. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem 275:29308-29317.
27. Taya Y, O'Kane S, Ferguson MW. 1999. Pathogenesis of cleft palate in TGF-beta-3 knock out mice. Development 126:3869-3879.
28. Waldrip WR, Bikoff EK, Hoodless PA, Wrana JL, Robertson EJ. 1998. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92:797-808.
29. Weinstein M, Yang X, Li C, Xu X, Gotay J, Deng CX. 1998. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc Natl Acad Sci U S A 95:9378-9383.
30. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18:1280-1291.
31. Zhu Y, Richardson JA, Parada L F, Graff JM. 1998. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94: 703-714.